nodes	percent_of_prediction	percent_of_DWPC	metapath
Glucosamine—MMP9—amyotrophic lateral sclerosis	0.816	1	CbGaD
Glucosamine—MMP9—hindlimb—amyotrophic lateral sclerosis	0.00919	0.248	CbGeAlD
Glucosamine—MMP9—appendage—amyotrophic lateral sclerosis	0.00789	0.213	CbGeAlD
Glucosamine—MMP9—embryo—amyotrophic lateral sclerosis	0.00262	0.0707	CbGeAlD
Glucosamine—IFNG—spinal cord—amyotrophic lateral sclerosis	0.00232	0.0627	CbGeAlD
Glucosamine—NFKB2—brain—amyotrophic lateral sclerosis	0.00221	0.0596	CbGeAlD
Glucosamine—IFNG—nervous system—amyotrophic lateral sclerosis	0.00196	0.0529	CbGeAlD
Glucosamine—IFNG—central nervous system—amyotrophic lateral sclerosis	0.00189	0.0509	CbGeAlD
Glucosamine—IFNG—brain—amyotrophic lateral sclerosis	0.0015	0.0404	CbGeAlD
Glucosamine—MMP9—spinal cord—amyotrophic lateral sclerosis	0.00149	0.0403	CbGeAlD
Glucosamine—MMP9—nervous system—amyotrophic lateral sclerosis	0.00126	0.0339	CbGeAlD
Glucosamine—MMP9—central nervous system—amyotrophic lateral sclerosis	0.00121	0.0327	CbGeAlD
Glucosamine—MMP9—brain—amyotrophic lateral sclerosis	0.000961	0.0259	CbGeAlD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.000855	0.00582	CbGpPWpGaD
Glucosamine—NFKB2—MyD88-independent cascade—ATF1—amyotrophic lateral sclerosis	0.000847	0.00577	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—BDNF—amyotrophic lateral sclerosis	0.000845	0.00575	CbGpPWpGaD
Glucosamine—NFKB2—Signaling by Interleukins—SQSTM1—amyotrophic lateral sclerosis	0.000842	0.00573	CbGpPWpGaD
Glucosamine—IFNG—Hypertrophy Model—VEGFA—amyotrophic lateral sclerosis	0.00084	0.00572	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000811	0.00552	CbGpPWpGaD
Glucosamine—IFNG—IL1 and megakaryotyces in obesity—MMP9—amyotrophic lateral sclerosis	0.000808	0.0055	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IGFBP3—amyotrophic lateral sclerosis	0.000807	0.00549	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000795	0.00541	CbGpPWpGaD
Glucosamine—IFNG—Calcium signaling in the CD4+ TCR pathway—PTGS2—amyotrophic lateral sclerosis	0.000792	0.00539	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000783	0.00533	CbGpPWpGaD
Glucosamine—NFKB2—Activated TLR4 signalling—ATF1—amyotrophic lateral sclerosis	0.000762	0.00519	CbGpPWpGaD
Glucosamine—IFNG—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000736	0.00501	CbGpPWpGaD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP9—amyotrophic lateral sclerosis	0.00073	0.00497	CbGpPWpGaD
Glucosamine—NFKB2—Toll Like Receptor 4 (TLR4) Cascade—ATF1—amyotrophic lateral sclerosis	0.000717	0.00488	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000709	0.00483	CbGpPWpGaD
Glucosamine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000709	0.00483	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000701	0.00477	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—SQSTM1—amyotrophic lateral sclerosis	0.000698	0.00475	CbGpPWpGaD
Glucosamine—NFKB2—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000688	0.00469	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—CASP9—amyotrophic lateral sclerosis	0.000685	0.00466	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000675	0.00459	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000661	0.0045	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—CASP9—amyotrophic lateral sclerosis	0.000652	0.00444	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000644	0.00439	CbGpPWpGaD
Glucosamine—NFKB2—Toll-Like Receptors Cascades—ATF1—amyotrophic lateral sclerosis	0.000638	0.00435	CbGpPWpGaD
Glucosamine—NFKB2—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.000637	0.00434	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.00063	0.00429	CbGpPWpGaD
Glucosamine—TNF—TNF receptor signaling pathway —SQSTM1—amyotrophic lateral sclerosis	0.000627	0.00427	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—SOD1—amyotrophic lateral sclerosis	0.000615	0.00418	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—CASP9—amyotrophic lateral sclerosis	0.000602	0.0041	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—SOD1—amyotrophic lateral sclerosis	0.000585	0.00398	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—SQSTM1—amyotrophic lateral sclerosis	0.00056	0.00381	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000557	0.00379	CbGpPWpGaD
Glucosamine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000551	0.0149	CbGeAlD
Glucosamine—MMP9—AGE/RAGE pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000551	0.00375	CbGpPWpGaD
Glucosamine—MMP9—Angiogenesis—VEGFA—amyotrophic lateral sclerosis	0.00055	0.00374	CbGpPWpGaD
Glucosamine—MMP9—Plasma membrane estrogen receptor signaling—IGF1—amyotrophic lateral sclerosis	0.000549	0.00373	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—IGF1—amyotrophic lateral sclerosis	0.000548	0.00373	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000533	0.00363	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000533	0.00363	CbGpPWpGaD
Glucosamine—TNF—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000515	0.00351	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—MAPT—amyotrophic lateral sclerosis	0.000515	0.00351	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000512	0.00349	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.000503	0.00342	CbGpPWpGaD
Glucosamine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000492	0.0133	CbGeAlD
Glucosamine—IFNG—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000479	0.00326	CbGpPWpGaD
Glucosamine—IFNG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000475	0.00324	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000473	0.00322	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—CASP9—amyotrophic lateral sclerosis	0.000472	0.00321	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000463	0.00315	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000453	0.00309	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000434	0.00296	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000429	0.00292	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000422	0.00287	CbGpPWpGaD
Glucosamine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000414	0.0112	CbGeAlD
Glucosamine—MMP9—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000414	0.00282	CbGpPWpGaD
Glucosamine—NFKB2—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000402	0.00274	CbGpPWpGaD
Glucosamine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000399	0.0108	CbGeAlD
Glucosamine—NFKB2—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000393	0.00268	CbGpPWpGaD
Glucosamine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00039	0.0105	CbGeAlD
Glucosamine—MMP9—Endochondral Ossification—IGF1—amyotrophic lateral sclerosis	0.000384	0.00262	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000376	0.00256	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—CASP9—amyotrophic lateral sclerosis	0.000373	0.00254	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.00037	0.00252	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000363	0.00247	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—CASP9—amyotrophic lateral sclerosis	0.000363	0.00247	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000363	0.00247	CbGpPWpGaD
Glucosamine—NFKB2—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00036	0.00245	CbGpPWpGaD
Glucosamine—IFNG—SHP2 signaling—VEGFA—amyotrophic lateral sclerosis	0.000358	0.00244	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—PFN1—amyotrophic lateral sclerosis	0.000356	0.00242	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.000346	0.00235	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000343	0.00234	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000343	0.00234	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000343	0.00234	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—MMP9—amyotrophic lateral sclerosis	0.000343	0.00234	CbGpPWpGaD
Glucosamine—TNF—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000341	0.00232	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—IGF1—amyotrophic lateral sclerosis	0.000341	0.00232	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000341	0.00232	CbGpPWpGaD
Glucosamine—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—APOE—amyotrophic lateral sclerosis	0.000331	0.00225	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.00033	0.00224	CbGpPWpGaD
Glucosamine—IFNG—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000326	0.00222	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.000322	0.00219	CbGpPWpGaD
Glucosamine—MMP9—Signaling by SCF-KIT—ERBB4—amyotrophic lateral sclerosis	0.000319	0.00217	CbGpPWpGaD
Glucosamine—IFNG—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000319	0.00217	CbGpPWpGaD
Glucosamine—CYP2E1—brain—amyotrophic lateral sclerosis	0.000317	0.00855	CbGeAlD
Glucosamine—TNF—Matrix Metalloproteinases—MMP9—amyotrophic lateral sclerosis	0.000314	0.00214	CbGpPWpGaD
Glucosamine—TNF—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—amyotrophic lateral sclerosis	0.000308	0.00209	CbGpPWpGaD
Glucosamine—NFKB2—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000301	0.00205	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—MAPT—amyotrophic lateral sclerosis	0.0003	0.00204	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000299	0.00204	CbGpPWpGaD
Glucosamine—TNF—amb2 Integrin signaling—MMP9—amyotrophic lateral sclerosis	0.000298	0.00203	CbGpPWpGaD
Glucosamine—TNF—Ceramide signaling pathway—IGF1—amyotrophic lateral sclerosis	0.000296	0.00202	CbGpPWpGaD
Glucosamine—MMP9—LPA receptor mediated events—CASP3—amyotrophic lateral sclerosis	0.000296	0.00201	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	0.000292	0.00199	CbGpPWpGaD
Glucosamine—MMP9—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.000289	0.00196	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—MAPT—amyotrophic lateral sclerosis	0.000282	0.00192	CbGpPWpGaD
Glucosamine—IFNG—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.00028	0.0019	CbGpPWpGaD
Glucosamine—IFNG—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000276	0.00188	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—CASP3—amyotrophic lateral sclerosis	0.000275	0.00187	CbGpPWpGaD
Glucosamine—TNF—Cardiac Hypertrophic Response—IGF1—amyotrophic lateral sclerosis	0.000266	0.00181	CbGpPWpGaD
Glucosamine—TNF—Regulation of toll-like receptor signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000259	0.00176	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—C3—amyotrophic lateral sclerosis	0.000258	0.00176	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000258	0.00175	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Glucosamine—TNF—FAS pathway and Stress induction of HSP regulation—CASP3—amyotrophic lateral sclerosis	0.000254	0.00173	CbGpPWpGaD
Glucosamine—MMP9—Endochondral Ossification—VEGFA—amyotrophic lateral sclerosis	0.000251	0.00171	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000247	0.00168	CbGpPWpGaD
Glucosamine—IFNG—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000244	0.00166	CbGpPWpGaD
Glucosamine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000241	0.00164	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.000241	0.00164	CbGpPWpGaD
Glucosamine—TNF—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.00024	0.00163	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000239	0.00163	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.000238	0.00162	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000236	0.00161	CbGpPWpGaD
Glucosamine—IFNG—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000233	0.00159	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000232	0.00158	CbGpPWpGaD
Glucosamine—MMP9—Degradation of the extracellular matrix—CASP3—amyotrophic lateral sclerosis	0.000227	0.00155	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000226	0.00154	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000222	0.00151	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000222	0.00151	CbGpPWpGaD
Glucosamine—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000221	0.0015	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.000212	0.00144	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000207	0.00141	CbGpPWpGaD
Glucosamine—IFNG—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000205	0.0014	CbGpPWpGaD
Glucosamine—NFKB2—DNA Damage Response (only ATM dependent)—TP53—amyotrophic lateral sclerosis	0.000202	0.00137	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000201	0.00137	CbGpPWpGaD
Glucosamine—NFKB2—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.0002	0.00136	CbGpPWpGaD
Glucosamine—TNF—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.0002	0.00136	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.000199	0.00135	CbGpPWpGaD
Glucosamine—TNF—Caspase Cascade in Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000199	0.00135	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000197	0.00134	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000195	0.00133	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000189	0.00129	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.000189	0.00129	CbGpPWpGaD
Glucosamine—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000189	0.00129	CbGpPWpGaD
Glucosamine—MMP9—EPH-Ephrin signaling—VEGFA—amyotrophic lateral sclerosis	0.000185	0.00126	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000181	0.00123	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000179	0.00122	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000178	0.00121	CbGpPWpGaD
Glucosamine—MMP9—AP-1 transcription factor network—TP53—amyotrophic lateral sclerosis	0.000176	0.0012	CbGpPWpGaD
Glucosamine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—amyotrophic lateral sclerosis	0.000176	0.0012	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000171	0.00117	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000169	0.00115	CbGpPWpGaD
Glucosamine—IFNG—Senescence and Autophagy in Cancer—TP53—amyotrophic lateral sclerosis	0.000168	0.00115	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.000167	0.00114	CbGpPWpGaD
Glucosamine—IFNG—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000163	0.00111	CbGpPWpGaD
Glucosamine—MMP9—Validated targets of C-MYC transcriptional activation—TP53—amyotrophic lateral sclerosis	0.00016	0.00109	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000156	0.00106	CbGpPWpGaD
Glucosamine—IFNG—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000153	0.00104	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000153	0.00104	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000153	0.00104	CbGpPWpGaD
Glucosamine—TNF—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000151	0.00103	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000151	0.00103	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000146	0.000992	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000144	0.000982	CbGpPWpGaD
Glucosamine—NFKB2—Innate Immune System—C3—amyotrophic lateral sclerosis	0.00014	0.000953	CbGpPWpGaD
Glucosamine—TNF—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000135	0.000922	CbGpPWpGaD
Glucosamine—TNF—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000133	0.000908	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000132	0.000898	CbGpPWpGaD
Glucosamine—TNF—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.00013	0.000884	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000128	0.000874	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000121	0.000822	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ATF1—amyotrophic lateral sclerosis	0.00012	0.00082	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.00012	0.000814	CbGpPWpGaD
Glucosamine—MMP9—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000116	0.000791	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000115	0.000781	CbGpPWpGaD
Glucosamine—TNF—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000113	0.000771	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000112	0.000764	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000111	0.000756	CbGpPWpGaD
Glucosamine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000107	0.000727	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000105	0.000718	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000105	0.000714	CbGpPWpGaD
Glucosamine—IFNG—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000104	0.000708	CbGpPWpGaD
Glucosamine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	9.94e-05	0.000677	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—ERBB4—amyotrophic lateral sclerosis	9.82e-05	0.000668	CbGpPWpGaD
Glucosamine—TNF—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	9.81e-05	0.000668	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	9.81e-05	0.000668	CbGpPWpGaD
Glucosamine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	9.8e-05	0.000667	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	9.79e-05	0.000666	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ATF1—amyotrophic lateral sclerosis	9.76e-05	0.000664	CbGpPWpGaD
Glucosamine—MMP9—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	9.52e-05	0.000648	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	9.34e-05	0.000636	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CASP9—amyotrophic lateral sclerosis	9.29e-05	0.000633	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—CD40LG—amyotrophic lateral sclerosis	9.23e-05	0.000628	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	9.2e-05	0.000627	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	8.92e-05	0.000607	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	8.88e-05	0.000604	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VCP—amyotrophic lateral sclerosis	8.72e-05	0.000594	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	8.45e-05	0.000575	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	8.37e-05	0.00057	CbGpPWpGaD
Glucosamine—NFKB2—Immune System—C3—amyotrophic lateral sclerosis	8.16e-05	0.000555	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	8.13e-05	0.000554	CbGpPWpGaD
Glucosamine—IFNG—Immune System—ERBB4—amyotrophic lateral sclerosis	7.95e-05	0.000541	CbGpPWpGaD
Glucosamine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	7.67e-05	0.000522	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.62e-05	0.000518	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.62e-05	0.000518	CbGpPWpGaD
Glucosamine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	7.56e-05	0.000515	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	7.55e-05	0.000514	CbGpPWpGaD
Glucosamine—TNF—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	7.53e-05	0.000513	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	7.5e-05	0.000511	CbGpPWpGaD
Glucosamine—IFNG—Immune System—CD40LG—amyotrophic lateral sclerosis	7.48e-05	0.000509	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	7.42e-05	0.000505	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.23e-05	0.000492	CbGpPWpGaD
Glucosamine—TNF—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	7.12e-05	0.000484	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.97e-05	0.000474	CbGpPWpGaD
Glucosamine—MMP9—Axon guidance—VEGFA—amyotrophic lateral sclerosis	6.86e-05	0.000467	CbGpPWpGaD
Glucosamine—IFNG—Immune System—C3—amyotrophic lateral sclerosis	6.61e-05	0.00045	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.48e-05	0.000441	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	6.41e-05	0.000436	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	6.09e-05	0.000414	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	5.88e-05	0.0004	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	5.88e-05	0.0004	CbGpPWpGaD
Glucosamine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	5.72e-05	0.000389	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	5.51e-05	0.000375	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.48e-05	0.000373	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	5.37e-05	0.000366	CbGpPWpGaD
Glucosamine—TNF—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	5.36e-05	0.000365	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.1e-05	0.000347	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	5e-05	0.00034	CbGpPWpGaD
Glucosamine—MMP9—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	4.89e-05	0.000333	CbGpPWpGaD
Glucosamine—TNF—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.84e-05	0.00033	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.78e-05	0.000325	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	4.7e-05	0.00032	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	4.55e-05	0.00031	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	4.25e-05	0.000289	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.17e-05	0.000284	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.9e-05	0.000265	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	3.85e-05	0.000262	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.66e-05	0.000249	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—MMP9—amyotrophic lateral sclerosis	3.34e-05	0.000227	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.24e-05	0.00022	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	3.22e-05	0.000219	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.16e-05	0.000215	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.01e-05	0.000205	CbGpPWpGaD
Glucosamine—TNF—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	3e-05	0.000204	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	2.97e-05	0.000202	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000184	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.49e-05	0.00017	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	2.44e-05	0.000166	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.23e-05	0.000152	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.92e-05	0.000131	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.7e-05	0.000116	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.63e-05	0.000111	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000106	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.53e-05	0.000104	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.31e-05	8.93e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	1.29e-05	8.75e-05	CbGpPWpGaD
Glucosamine—MMP9—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.23e-05	8.37e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	8.2e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	9.92e-06	6.75e-05	CbGpPWpGaD
Glucosamine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.81e-06	5.99e-05	CbGpPWpGaD
Glucosamine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.79e-06	4.63e-05	CbGpPWpGaD
